Barclays’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.94M | Buy |
+26,900
| New | +$7.99M | ﹤0.01% | 1575 |
|
|
2025
Q2 | – | Sell |
-200,000
| Closed | -$53.1M | – | 5300 |
|
|
2025
Q1 | $53.1M | Buy |
+200,000
| New | +$49.3M | 0.02% | 633 |
|
|
2021
Q1 | – | Sell |
-11,100
| Closed | -$2.02M | – | 4748 |
|
|
2020
Q4 | $2.02M | Hold |
11,100
| – | – | ﹤0.01% | 2227 |
|
|
2020
Q3 | $1.86M | Sell |
11,100
-4,700
| -30% | -$792K | ﹤0.01% | 2174 |
|
|
2020
Q2 | $2.57M | Sell |
15,800
-34,300
| -68% | -$6.15M | ﹤0.01% | 1878 |
|
|
2020
Q1 | $8.66M | Buy |
50,100
+31,000
| +162% | +$6.17M | 0.01% | 1080 |
|
|
2019
Q4 | $3.83M | Sell |
19,100
-7,400
| -28% | -$1.52M | ﹤0.01% | 2302 |
|
|
2019
Q3 | $5.6M | Buy |
26,500
+17,400
| +191% | +$3.64M | ﹤0.01% | 1754 |
|
|
2019
Q2 | $1.77M | Sell |
9,100
-5,800
| -39% | -$1.07M | ﹤0.01% | 3068 |
|
|
2019
Q1 | $2.45M | Sell |
14,900
-83,200
| -85% | -$14.7M | ﹤0.01% | 2356 |
|
|
2018
Q4 | $18.5M | Buy |
98,100
+64,300
| +190% | +$11.9M | 0.01% | 790 |
|
|
2018
Q3 | $5.75M | Sell |
33,800
-107,500
| -76% | -$18.1M | ﹤0.01% | 1673 |
|
|
2018
Q2 | $23.2M | Sell |
141,300
-94,600
| -40% | -$15.5M | 0.02% | 715 |
|
|
2018
Q1 | $38.2M | Buy |
235,900
+148,200
| +169% | +$23.6M | 0.03% | 532 |
|
|
2017
Q4 | $12.8M | Sell |
87,700
-26,800
| -23% | -$3.82M | 0.01% | 1058 |
|
|
2017
Q3 | $15.5M | Buy |
114,500
+61,200
| +115% | +$7.73M | 0.02% | 785 |
|
|
2017
Q2 | $6.67M | Buy |
53,300
+34,400
| +182% | +$4.11M | 0.01% | 1260 |
|
|
2017
Q1 | $2.25M | Buy |
18,900
+5,000
| +36% | +$601K | ﹤0.01% | 1980 |
|
|
2016
Q4 | $1.6M | Buy |
13,900
+6,800
| +96% | +$757K | ﹤0.01% | 2312 |
|
|
2016
Q3 | $742K | Sell |
7,100
-3,700
| -34% | -$386K | ﹤0.01% | 2906 |
|
|
2016
Q2 | $1.05M | Sell |
10,800
-5,500
| -34% | -$520K | ﹤0.01% | 2566 |
|
|
2016
Q1 | $1.56M | Sell |
16,300
-18,500
| -53% | -$1.68M | ﹤0.01% | 2142 |
|
|
2015
Q4 | $3.13M | Sell |
34,800
-41,500
| -54% | -$3.91M | ﹤0.01% | 1670 |
|
|
2015
Q3 | $7.02M | Buy |
76,300
+33,600
| +79% | +$3.19M | 0.01% | 1149 |
|
|
2015
Q2 | $3.97M | Buy |
42,700
+28,900
| +209% | +$2.7M | ﹤0.01% | 1686 |
|
|
2015
Q1 | $1.3M | Sell |
13,800
-11,900
| -46% | -$1.1M | ﹤0.01% | 2728 |
|
|
2014
Q4 | $2.26M | Hold |
25,700
| – | – | ﹤0.01% | 2417 |
|
|
2014
Q3 | $2.03M | Buy |
25,700
+9,100
| +55% | +$686K | ﹤0.01% | 2653 |
|
|
2014
Q2 | $1.16M | Sell |
16,600
-15,700
| -49% | -$1.11M | ﹤0.01% | 3184 |
|
|
2014
Q1 | $2.39M | Sell |
32,300
-50,300
| -61% | -$3.79M | ﹤0.01% | 2372 |
|
|
2013
Q4 | $6.44M | Sell |
82,600
-8,500
| -9% | -$666K | 0.01% | 1602 |
|
|
2013
Q3 | $6.65M | Buy |
91,100
+33,400
| +58% | +$2.46M | 0.01% | 1455 |
|
|
2013
Q2 | $4.38M | Buy |
+57,700
| New | +$3.79M | 0.01% | 1732 |
|
Other funds holding CME
VCM
VPM
Barclays's CME Position: Q1 2026 in Review
Barclays reduced its CME Group (CME) stake by 23% in Q1 2026, selling an estimated $93.6M and leaving 1,045,739 shares worth $309M. The position accounts for 0.07% of the portfolio, ranked #199.
Barclays first reported a position in CME in Q2 2013 and has held it in 52 quarters since. The position peaked at $411M in Q3 2025. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.
- Barclays held 1,045,739 shares of CME Group worth $309M as of Q1 2026.
- Barclays sold 314,988 CME Group shares in Q1 2026, an estimated $93.6M.
- CME Group made up 0.07% of Barclays's portfolio in Q1 2026, its #199 holding.
- Barclays first reported a position in CME Group in Q2 2013 and has held it in 52 quarters since.
- Barclays's CME Group position peaked at $411M in Q3 2025.
- 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.